Next Article in Journal
Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against Onchocerca gutturosa in Gambia
Previous Article in Journal
Doxorubicin Conjugated γ-Globulin Functionalised Gold Nanoparticles: A pH-Responsive Bioinspired Nanoconjugate Approach for Advanced Chemotherapeutics
Previous Article in Special Issue
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(2), 209; https://doi.org/10.3390/pharmaceutics16020209
Action Date Notes Link
article pdf uploaded. 31 January 2024 15:08 CET Version of Record https://www.mdpi.com/1999-4923/16/2/209/pdf-vor
article xml file uploaded 1 February 2024 04:21 CET Original file -
article xml uploaded. 1 February 2024 04:21 CET Update https://www.mdpi.com/1999-4923/16/2/209/xml
article pdf uploaded. 1 February 2024 04:21 CET Updated version of record https://www.mdpi.com/1999-4923/16/2/209/pdf
article html file updated 1 February 2024 04:23 CET Original file https://www.mdpi.com/1999-4923/16/2/209/html
Back to TopTop